Twist Bioscience Corporation TWST Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's accounts receivable?
- Twist Bioscience Corporation (TWST) reported accounts receivable of $64.15M in Q1 2026.
- How has Twist Bioscience Corporation's accounts receivable changed year-over-year?
- Twist Bioscience Corporation's accounts receivable increased by 28.4% year-over-year, from $49.95M to $64.15M.
- What is the long-term trend for Twist Bioscience Corporation's accounts receivable?
- Over 5 years (2020 to 2025), Twist Bioscience Corporation's accounts receivable has grown at a 17.2% compound annual growth rate (CAGR), from $25.79M to $57.02M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.